FDA device enforcement records identify American Contract Systems Inc of Tiffin, Ohio as the recalling firm behind several Class II recalls posted in 2026. The records describe the company's documented output as medical convenience kits: assembled procedure packs that combine third-party components such as BD CliniClean Pericare Wipes within BD Urinary Catheter Trays, or Medline Red Rubber Intermittent Catheters and catheter trays. The filings place the company at the kit-assembly layer of the device supply chain, where a component-level action by an upstream manufacturer becomes a kit-level recall carrying the assembler's name. [1][4][8]

Documented kit families and component sourcing

The FDA records list specific catalog numbers and models. Z-3294-2026 covers an Abdominal Hysterectomy kit (MHAH55AM), a LAVH-LAP Colon kit (SPLL54U) and a Vag Hyst Pack (SPVH62P). Z-3293-2026 covers a Cardiac Heart Bundle NS (LMCH99P) and an Open Heart 2 kit (RCOH62C). Z-3292-2026 covers a Robotic Pack (MHRB88AO). Each of these three records describes kits containing BD CliniClean Pericare Wipes within BD Urinary Catheter Trays, and each carries the same product quantity of 1,804 kits total. [1][2][3]

A separate event, event 99514, covers two additional kits: a D & C Pack (LLPD90H) with 12 units and a CV B Pack (TNCB10AP) with 30 units. Both records state the kits contain Medline's Red Rubber Intermittent Catheters (8Fr-22 Fr) and Red Rubber Intermittent Catheter Trays, and that Medline Industries, LP identified representative samples that did not meet applicable performance specifications. [4][5]

Recall scope, dates and distribution

The pericare-wipe recalls were initiated by the firm on August 10, 2026, with center classification on September 25, 2026 and report dates of October 7, 2026. All three are Class II, voluntary firm-initiated actions with status listed as Ongoing, and initial firm notification by letter. Distribution is described as US nationwide in Iowa, Minnesota, Wisconsin and South Dakota. [1][2][3]

The catheter-related event was initiated June 29, 2026, classified August 21, 2026 and reported September 2, 2026, also Class II, voluntary and Ongoing, with letter notification. Distribution for those two kits is described as US nationwide in Iowa and Ohio. FDA recall database pages for ACS, American Contract System list a firm-initiated date of August 10, 2026 and a page update of October 27, 2026. [4][5][6][7]

Stated hazard rationale

The enforcement records state the reason for the wipe-related recalls: the kits contain manufacturer-recalled pericare wipes that may be contaminated with a lubricant used during manufacturing. The records describe possible localized skin effects such as irritation, erythema or mild inflammation, and note that skipping pericare because contaminated wipes were discarded may increase risk of localized infection or catheter-associated urinary tract infection. These are the agency-recorded rationales, not independent assessments. [1][2][3]

Recall Canary, an independent publisher not affiliated with any government agency, summarized the same notice as 1,804 medical convenience kits containing BD CliniClean Pericare Wipes, describing skin irritation or infection risk and moderate risk. Recall Weekly likewise characterized the action as a Class II recall of convenience kits for contaminated pericare wipes. [8][10]

What the record does not establish

The numbered sources document kit catalog numbers, lot codes, UDI-DIs, quantities, distribution states and recall classifications. They do not establish corporate ownership, parent or brand relationships, a website, customer list, manufacturing certifications or commercial availability beyond the recalled lots. The Tiffin address appears as the recalling firm's filing address and is not treated here as a verified headquarters. [1][4][8]